Pure Global

Effect of Epigallocatechin Gallate supplementation on type 2 diabetes - Trial IRCT20181219042047N1

Access comprehensive clinical trial information for IRCT20181219042047N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Artesh University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20181219042047N1
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial โ€ข IRCT20181219042047N1
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Epigallocatechin Gallate supplementation on type 2 diabetes
Effects of Epigallocatechin Gallate Supplementation on the Insulin Resistence and Inflammatory Factors in Patients with Type 2 Diabetes

Study Focus

Interventional

drug

Sponsor & Location

Artesh University of Medical Sciences

Iran

Timeline & Enrollment

N/A

Dec 11, 2018

N/A

ICD-10 Classifications

Other specified diabetes mellitus without complications
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus
Other specified diabetes mellitus with other specified complications
Other specified diabetes mellitus with unspecified complications

Data Source

Iranian Registry Of Clinical Trial

IRCT20181219042047N1

Non-Device Trial